NCT04934774: Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances |
|
|
| Recruiting | 1 | 20 | RoW | CD7 CAR T cells | iCell Gene Therapeutics, iCAR Bio Therapeutics Ltd., Peking University Shenzhen Hospital | T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, T-cell Non-Hodgkin Lymphoma | 06/23 | 06/23 | | |
NCT05212584: CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma |
|
|
| Recruiting | 1 | 24 | RoW | CD7CAR T cells | iCell Gene Therapeutics, iCar Bio Therapeutics | Relapsed/Refractory, High Risk Hematologic Malignancies, T-ALL/Lymphoma | 06/24 | 06/24 | | |
